NCT02036190View on ClinicalTrials.gov

Ancillary T Cell Based Studies in SPIROMICS

CompletedOBSERVATIONAL

Enrollment

175

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Smoke Induced Lung Disease

Trial Locations (1)

94143

UCSF, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER

NCT02036190 - Ancillary T Cell Based Studies in SPIROMICS | Biotech Hunter | Biotech Hunter